Kappa Bioscience is a pioneer and innovator within the production of nutraceutical ingredients – primarily of vitamin K2, which plays a key role in improving heart, bone and immune system health through its regulation of calcium deposition. Kappa supports a healthy and sustainable society through its best-in-class ingredients in a wide range of forms and concentrations, and is focused on developing its ingredients for the dietary supplements market. Recognised for launching the first man-made menaquinone-7 in its natural form, marketed as K2VITAL®, Kappa works and collaborates with category-leading nutritional supplement consumer companies, digitally native brands, and distributors across the globe.